MATRIX-A Trademark

Trademark Overview

On Monday, November 15, 2021, a trademark application was filed for MATRIX-A with the United States Patent and Trademark Office. The USPTO has given the MATRIX-A trademark a serial number of 79337951. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Novavax AB. The MATRIX-A trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for use with vaccines; adjuvants for medical purposes
matrix-a

General Information

Serial Number79337951
Word MarkMATRIX-A
Filing DateMonday, November 15, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7008611
Registration DateTuesday, March 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements

Goods and ServicesAdjuvants for use with vaccines; adjuvants for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax AB
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameNovavax AB
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressSE
Party NameNovavax AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressSE

Trademark Events

Event DateEvent Description
Monday, August 7, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 19, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 19, 2023FINAL DISPOSITION PROCESSED
Wednesday, June 28, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTIFICATION PROCESSED BY IB
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 14, 2022REFUSAL PROCESSED BY IB
Wednesday, October 26, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 26, 2022REFUSAL PROCESSED BY MPU
Wednesday, September 7, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 6, 2022NON-FINAL ACTION WRITTEN
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Tuesday, April 19, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 14, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

matrix adjuvants purposes vaccines medical